Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study.

• Main Authors: Catherine M Bjerum (Author), Benjamin G Koudou (Author), Allassane F Ouattara (Author), Daphne Lew (Author), Charles W Goss (Author), Pascal T Gabo (Author), Christopher L King (Author), Peter U Fischer (Author), Gary J Weil (Author), Philip J Budge (Author)
• Format: Book
• Published: Public Library of Science (PLoS), 2023-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

<h4>Background</h4>Moxidectin is a macrocyclic lactone registered for the treatment of human onchocerciasis. The drug has a good safety profile, large volume of distribution and a long elimination half-life. This paper reports tolerability data from the first use of moxidectin in persons...